{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T18:19:19Z","timestamp":1778869159187,"version":"3.51.4"},"reference-count":36,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["RE\/18\/4\/34215"],"award-info":[{"award-number":["RE\/18\/4\/34215"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["102568\/#191351"],"award-info":[{"award-number":["102568\/#191351"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["2016822"],"award-info":[{"award-number":["2016822"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["107244"],"award-info":[{"award-number":["107244"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["106732"],"award-info":[{"award-number":["106732"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013342","name":"NIHR Imperial Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013342","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001030","name":"National Heart Foundation of Australia","doi-asserted-by":"publisher","award":["103082"],"award-info":[{"award-number":["103082"]}],"id":[{"id":"10.13039\/501100001030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartrhythmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Rhythm"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.hrthm.2024.12.014","type":"journal-article","created":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T22:35:40Z","timestamp":1734129340000},"page":"2906-2916","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Noninvasive assessment of hydroquinidine effect in Brugada syndrome (QUIET BrS)"],"prefix":"10.1016","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9502-2493","authenticated-orcid":false,"given":"Julia C.","family":"Isbister","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Strocchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Riedy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Yeates","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Belinda","family":"Gray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma S.","family":"Singer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard D.","family":"Bagnall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jodie","family":"Ingles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hariharan","family":"Raju","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Semsarian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven A.","family":"Niederer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymond W.","family":"Sy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.hrthm.2024.12.014_bib1","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1161\/CIRCEP.115.003109","article-title":"Management of Brugada syndrome: thirty-three-year experience using electrophysiologically guided therapy with class 1A antiarrhythmic drugs","volume":"8","author":"Belhassen","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2024.12.014_bib2","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1016\/j.jacc.2003.12.046","article-title":"Hydroquinidine therapy in Brugada syndrome","volume":"43","author":"Hermida","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2024.12.014_bib3","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.jacep.2018.10.007","article-title":"Challenge and impact of quinidine access in sudden death syndromes: a national experience","volume":"5","author":"Malhi","year":"2019","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.hrthm.2024.12.014_bib4","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.hrthm.2017.04.019","article-title":"The QUIDAM study: hydroquinidine therapy for the management of Brugada syndrome patients at high arrhythmic risk","volume":"14","author":"Andorin","year":"2017","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2024.12.014_bib5","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1093\/eurheartj\/ehac262","article-title":"2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death","volume":"43","author":"Zeppenfeld","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2024.12.014_bib6","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1016\/j.jacc.2018.09.037","article-title":"Electroanatomic and pathologic right ventricular outflow tract abnormalities in patients with Brugada syndrome","volume":"72","author":"Pieroni","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2024.12.014_bib7","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.hrthm.2021.10.031","article-title":"Mechanism of the effects of sodium channel blockade on the arrhythmogenic substrate of Brugada syndrome","volume":"19","author":"Nademanee","year":"2022","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2024.12.014_bib8","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.hrthm.2021.10.030","article-title":"Multisite conduction block in the epicardial substrate of Brugada syndrome","volume":"19","author":"Haissaguerre","year":"2022","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2024.12.014_bib9","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1161\/01.CIR.100.15.1660","article-title":"Cellular basis for the Brugada syndrome and other mechanisms of arrhythmogenesis associated with ST-segment elevation","volume":"100","author":"Yan","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2024.12.014_bib10","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1016\/j.jacc.2014.01.067","article-title":"Abnormal repolarization as the basis for late potentials and fractionated electrograms recorded from epicardium in experimental models of Brugada syndrome","volume":"63","author":"Szel","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2024.12.014_bib11","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/291325a0","article-title":"Sodium current depression by lidocaine and quinidine in isolated ventricular cells","volume":"291","author":"Lee","year":"1981","journal-title":"Nature"},{"key":"10.1016\/j.hrthm.2024.12.014_bib12","first-page":"H704","article-title":"Quinidine-induced inhibition of transient outward current in cardiac muscle","volume":"253","author":"Imaizumi","year":"1987","journal-title":"Am J Physiol"},{"key":"10.1016\/j.hrthm.2024.12.014_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/JAHA.114.001615","article-title":"Comprehensive T wave morphology assessment in a randomized clinical study of dofetilide, quinidine, ranolazine, and verapamil","volume":"4","author":"Vicente","year":"2015","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.hrthm.2024.12.014_bib14","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1016\/j.hrthm.2008.09.008","article-title":"Role of late sodium current in modulating the proarrhythmic and antiarrhythmic effects of quinidine","volume":"5","author":"Wu","year":"2008","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2024.12.014_bib15","doi-asserted-by":"crossref","first-page":"4011","DOI":"10.1161\/01.CIR.96.11.4011","article-title":"Effects of quinidine on repolarization in canine epicardium, midmyocardium, and endocardium: I. In vitro study","volume":"96","author":"Sosunov","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2024.12.014_bib16","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1161\/01.CIR.81.3.790","article-title":"Frequency-dependent effects of quinidine on the ventricular action potential and QRS duration in humans","volume":"81","author":"Nademanee","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2024.12.014_bib17","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1540-8159.2005.09494.x","article-title":"Variable electrocardiographic effects of short-term quinidine sulfate administration in Brugada syndrome","volume":"28","author":"Watanabe","year":"2005","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.hrthm.2024.12.014_bib18","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1161\/CIRCULATIONAHA.114.013698","article-title":"Cardiac electrophysiological substrate underlying the ECG phenotype and electrogram abnormalities in Brugada syndrome patients","volume":"131","author":"Zhang","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2024.12.014_bib19","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.hrthm.2021.09.032","article-title":"High-density epicardial mapping in Brugada syndrome: depolarization and repolarization abnormalities","volume":"19","author":"Pannone","year":"2022","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2024.12.014_bib20","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jelectrocard.2022.04.001","article-title":"Dispersion of repolarization increases with cardiac resynchronization therapy and is associated with left ventricular reverse remodeling","volume":"72","author":"Elliott","year":"2022","journal-title":"J Electrocardiol"},{"key":"10.1016\/j.hrthm.2024.12.014_bib21","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/j.hrthm.2009.05.007","article-title":"Role of signal-averaged electrocardiograms in arrhythmic risk stratification of patients with Brugada syndrome: a prospective study","volume":"6","author":"Huang","year":"2009","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2024.12.014_bib22","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1161\/CIRCEP.115.003366","article-title":"ST-segment elevation and fractionated electrograms in Brugada syndrome patients arise from the same structurally abnormal subepicardial RVOT area but have a different mechanism","volume":"8","author":"Ten Sande","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2024.12.014_bib23","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.hrthm.2009.10.007","article-title":"Mechanism of right precordial ST-segment elevation in structural heart disease: excitation failure by current-to-load mismatch","volume":"7","author":"Hoogendijk","year":"2010","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2024.12.014_bib24","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1161\/01.CIR.75.2.379","article-title":"Monophasic action potential mapping in human subjects with normal electrocardiograms: direct evidence for the genesis of the T wave","volume":"75","author":"Franz","year":"1987","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2024.12.014_bib25","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1016\/j.jacc.2015.08.862","article-title":"Fibrosis, connexin-43, and conduction abnormalities in the Brugada syndrome","volume":"66","author":"Nademanee","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2024.12.014_bib26","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1093\/europace\/euy260","article-title":"Prolonged action potential duration and dynamic transmural action potential duration heterogeneity underlie vulnerability to ventricular tachycardia in patients undergoing ventricular tachycardia ablation","volume":"21","author":"Srinivasan","year":"2019","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2024.12.014_bib27","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.hrthm.2010.09.066","article-title":"ST segment elevation by current-to-load mismatch: an experimental and computational study","volume":"8","author":"Hoogendijk","year":"2011","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2024.12.014_bib28","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1161\/CIRCULATIONAHA.108.771401","article-title":"High-density substrate mapping in Brugada syndrome: combined role of conduction and repolarization heterogeneities in arrhythmogenesis","volume":"120","author":"Lambiase","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2024.12.014_bib29","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1161\/01.CIR.0000088781.99943.95","article-title":"Mapping and ablation of ventricular fibrillation associated with long-QT and Brugada syndromes","volume":"108","author":"Haissaguerre","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2024.12.014_bib30","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1253\/circj.CJ-11-0227","article-title":"Effects of quinidine on the action potential duration restitution property in the right ventricular outflow tract in patients with Brugada syndrome","volume":"75","author":"Ashino","year":"2011","journal-title":"Circ J"},{"key":"10.1016\/j.hrthm.2024.12.014_bib31","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1016\/j.hrthm.2012.08.027","article-title":"Long-term efficacy of low doses of quinidine on malignant arrhythmias in Brugada syndrome with an implantable cardioverter-defibrillator: a case series and literature review","volume":"9","author":"Marquez","year":"2012","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2024.12.014_bib32","doi-asserted-by":"crossref","DOI":"10.1111\/anec.12375","article-title":"Low-dose quinidine effectively reduced shocks in Brugada syndrome patients with an implantable cardioverter defibrillator: a Chinese case series report","volume":"22","author":"Shen","year":"2017","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"10.1016\/j.hrthm.2024.12.014_bib33","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.hrthm.2015.10.038","article-title":"Monomorphic ventricular tachycardia in patients with Brugada syndrome: a multicenter retrospective study","volume":"13","author":"Rodriguez-Manero","year":"2016","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2024.12.014_bib34","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.118.007143","article-title":"Efficacy and limitations of quinidine in patients with Brugada syndrome","volume":"12","author":"Mazzanti","year":"2019","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2024.12.014_bib35","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.hrthm.2022.01.034","article-title":"SCN5A mutation in Brugada syndrome is associated with substrate severity detected by electrocardiographic imaging and high-density electroanatomic mapping","volume":"19","author":"Pannone","year":"2022","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2024.12.014_bib36","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1093\/europace\/euaa165","article-title":"Electrocardiographic imaging for cardiac arrhythmias and resynchronization therapy","volume":"22","author":"Pereira","year":"2020","journal-title":"Europace"}],"container-title":["Heart Rhythm"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527124036592?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527124036592?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T18:04:06Z","timestamp":1778868246000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1547527124036592"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":36,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S1547527124036592"],"URL":"https:\/\/doi.org\/10.1016\/j.hrthm.2024.12.014","relation":{},"ISSN":["1547-5271"],"issn-type":[{"value":"1547-5271","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Noninvasive assessment of hydroquinidine effect in Brugada syndrome (QUIET BrS)","name":"articletitle","label":"Article Title"},{"value":"Heart Rhythm","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hrthm.2024.12.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Heart Rhythm Society. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}